Engineered Human Cardiac Tissue

Engineered Human Cardiac Tissue,10.1007/s00246-011-9888-9,Pediatric Cardiology,Kareen L. Kreutziger,Charles E. Murry

Engineered Human Cardiac Tissue   (Citations: 2)
BibTex | RIS | RefWorks Download
The human heart is the first organ to develop during embryogenesis and is arguably the most essential organ for life. However, after birth, the heart has very little capacity to repair malformations such as congenital heart defects or to regenerate after an injury such as myocardial infarction. Cardiac tissue engineering addresses the need for a therapeutic biologic implant to restore cardiac structure and muscle mass. This review highlights current research in cardiac tissue engineering that uses human cardiomyocytes derived from embryonic stem cells. Other human cell sources are discussed because future human therapies will benefit from novel techniques using human-induced pluripotent stem cells and cardiomyocytes derived from direct reprogramming of somatic cells. Furthermore, this review examines the main approaches to creating engineered cardiac tissue with synthetic scaffolds, natural scaffolds, or no exogenous scaffold (i.e., “scaffold free”). The choice of scaffold and cells ultimately depends on the goals of the therapy, so the review considers how congenital heart defects define the design parameters for cardiac tissue engineering needed for surgical repair in pediatric cardiac patients.
Journal: Pediatric Cardiology - PEDIAT CARDIOL , vol. 32, no. 3, pp. 334-341, 2011
Cumulative Annual
View Publication
The following links allow you to view full publications. These links are maintained by other sources not affiliated with Microsoft Academic Search.
    • ...Many different techniques have been used to assemble cardiac tissue mimics, from scaffold-free self assembled cells [31, 32] to the use of different biocompatible and/or biodegradable materials as scaffolds (for a review, see [33])...

    Sara S. Nuneset al. Stem Cell-Based Cardiac Tissue Engineering

Sort by: